[go: up one dir, main page]

DK0815105T3 - Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister - Google Patents

Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister

Info

Publication number
DK0815105T3
DK0815105T3 DK96905333T DK96905333T DK0815105T3 DK 0815105 T3 DK0815105 T3 DK 0815105T3 DK 96905333 T DK96905333 T DK 96905333T DK 96905333 T DK96905333 T DK 96905333T DK 0815105 T3 DK0815105 T3 DK 0815105T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
piperazine derivatives
substituted piperazine
heterocyclic substituted
tachykinin receptor
Prior art date
Application number
DK96905333T
Other languages
Danish (da)
English (en)
Inventor
Elizabeth M Kudlacz
Timothy P Burkholder
Tieu-Binh Le
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0815105T3 publication Critical patent/DK0815105T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK96905333T 1995-03-15 1996-02-06 Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister DK0815105T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40478895A 1995-03-15 1995-03-15
PCT/US1996/001437 WO1996028441A1 (en) 1995-03-15 1996-02-06 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists

Publications (1)

Publication Number Publication Date
DK0815105T3 true DK0815105T3 (da) 2002-01-21

Family

ID=23601038

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96905333T DK0815105T3 (da) 1995-03-15 1996-02-06 Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister

Country Status (21)

Country Link
US (2) US5840726A (es)
EP (1) EP0815105B1 (es)
JP (1) JP3825472B2 (es)
KR (1) KR19980703032A (es)
CN (1) CN1067068C (es)
AR (1) AR002715A1 (es)
AT (1) ATE206421T1 (es)
AU (1) AU697599B2 (es)
CA (1) CA2215333C (es)
DE (1) DE69615670T2 (es)
DK (1) DK0815105T3 (es)
ES (1) ES2164235T3 (es)
FI (1) FI973671A0 (es)
HU (1) HUP9702149A3 (es)
IL (1) IL117453A (es)
NO (1) NO314693B1 (es)
NZ (1) NZ302948A (es)
PT (1) PT815105E (es)
TW (1) TW464647B (es)
WO (1) WO1996028441A1 (es)
ZA (1) ZA961954B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU714931B2 (en) * 1995-12-18 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives as tachykinin antagonists
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7884097B2 (en) * 2003-09-05 2011-02-08 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994003483A1 (en) * 1992-07-30 1994-02-17 Chiron Corporation Endothelin receptor-binding compounds
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
DK0696280T3 (da) * 1993-05-06 1998-01-12 Merrell Pharma Inc Substituerede pyrrolidin-3-yl-alkyl-piperidiner anvendelige som tachykinin-antagonister
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
DE69615670T2 (de) 2002-08-08
AU697599B2 (en) 1998-10-08
HUP9702149A2 (hu) 1999-06-28
AU4930696A (en) 1996-10-02
ES2164235T3 (es) 2002-02-16
IL117453A (en) 2000-07-26
KR19980703032A (ko) 1998-09-05
FI973671L (fi) 1997-09-12
FI973671A7 (fi) 1997-09-12
HUP9702149A3 (en) 1999-07-28
CA2215333A1 (en) 1996-09-19
CA2215333C (en) 2002-01-01
CN1178529A (zh) 1998-04-08
JPH11501917A (ja) 1999-02-16
EP0815105A1 (en) 1998-01-07
ZA961954B (en) 1996-09-17
MX9706872A (es) 1997-11-29
AR002715A1 (es) 1998-04-29
TW464647B (en) 2001-11-21
NO974205L (no) 1997-11-13
NZ302948A (en) 2001-05-25
US5840726A (en) 1998-11-24
EP0815105B1 (en) 2001-10-04
NO314693B1 (no) 2003-05-05
NO974205D0 (no) 1997-09-12
WO1996028441A1 (en) 1996-09-19
IL117453A0 (en) 1996-07-23
DE69615670D1 (de) 2001-11-08
ATE206421T1 (de) 2001-10-15
PT815105E (pt) 2002-03-28
FI973671A0 (fi) 1997-09-12
JP3825472B2 (ja) 2006-09-27
CN1067068C (zh) 2001-06-13
US5864045A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
FI970107A7 (fi) Heterosyklisiä takykiniinireseptoriantagonisteja
DK0804419T3 (da) Quinolinderivater som tachykinin NK 3-receptor-antagonister
FI943247L (fi) Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
NO974686D0 (no) Nye substituerte piperazinderivater med tachykinin reseptor antagonist aktivitet
NZ307625A (en) 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
NO985225D0 (no) Indolderivater nyttige som endotelinreseptorantagonister
NO943348L (no) Kondenserte indolderivater som 5HT4-reseptorantagonister
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
FI963450A7 (fi) Morfoliinitakykiniinireseptoriantagonistien lääke-esiastetta
FI973283L (fi) 5-(4-substituoitu piperidinyyli-1)-3-aryyli-valeriaanahappojohdannaisia takykiniinireseptoriantagonisteina
NO974043D0 (no) Indolderivater som EAA-antagonister
NO985970L (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO992066D0 (no) Piperazinoderivater som neurokininantagonister
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
DK0815105T3 (da) Heterocyklisk substituerede piperazinonderivater som tachykininreceptor-antagonister
NO985972L (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
DK0940391T3 (da) Quinolinderivater som tachykinin-NK3-receptor-antagonister
HK1008990A (en) 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
NO963775L (no) Indol-derivater som CCK-reseptorantagonister